RMSD Analysis of Active Molecules Pred9 and Pred10 in Complex with A: Tubulin, B: CDK2, and C: EGFR.

<p>RMSD Analysis of Active Molecules Pred9 and Pred10 in Complex with A: Tubulin, B: CDK2, and C: EGFR.</p>

Saved in:

Bibliographic Details
Main Author:	Khadijah M. Al-Zaydi (11680831) (author)
Other Authors:	Soukayna Baammi (12436006) (author), Mohamed Moussaoui (15332714) (author)
Published:	2025
Subjects:	Biophysics Biochemistry Genetics Pharmacology Biotechnology Cancer Infectious Diseases Biological Sciences not elsewhere classified Chemical Sciences not elsewhere classified presenting significant challenges potent inhibitory activity monotherapies often fail favorable admet profiles enhance therapeutic outcomes current therapeutic strategies term efficacy due healthcare systems due six new compounds anticancer drug development div >< p address resistance mechanisms cancer remains one primarily due effective compounds reference drug key cancer drug resistance cancer cells validation coefficient target therapies strong leave related targets provide long promising strategy promising candidates phenylindole derivatives multitarget inhibition molecule 39 molecular docking leading causes external testing docked complexes despite advancements death globally compensatory pathways active molecule 814 ), 8 kcal 722 ). &# 8722
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items